Literature DB >> 6586630

Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species.

R H Gray, F A de la Iglesia.   

Abstract

Peroxisome proliferation, a well-documented subcellular reaction which follows the administration of hypolipidemic agents, has been well studied in rodents. However, quantitative studies of this phenomenon in other species of laboratory animals are not readily available even though these species are commonly used as predictors of tolerance or safety in humans. The quantitative stereologic studies reported here compared the effects of the new hypolipidemic agent gemfibrozil on hepatic peroxisomes of monkeys, dogs, hamsters and rats of both sexes under several treatment schedules. Gemfibrozil was administered to rats at 300 mg per kg per day for 1 year in the diet; to hamsters at 400 mg per kg per day for 2 weeks by diet admixture; to dogs at 300 mg per kg per day in gelatin capsules for 1 year; and to monkeys at 300 mg per kg day for 3 months by gavage. These dose levels were selected on the basis of tolerance from preliminary studies in each species. At the end of each experimental interval, liver samples were processed for quantitative microscopy. Peroxisomes from male rats were enlarged and the number of peroxisomes per cell were increased 7-fold over controls, resulting in a 20-fold increased peroxisome volume per cell. Statistically, significant increases also occurred in female rats and the difference between treated and controls was 3-fold for both number and volume of peroxisomes per cytoplasmic unit volume. In hamsters, peroxisomes were proliferated and were of significantly smaller size to the extent that the volume of cytoplasm occupied by peroxisomes was not significantly changed. In dogs, the number of peroxisomes per cell was increased and the volume fraction was significantly increased in females only. The number of peroxisomes in young monkeys did not change after treatment, and the peroxisome volume was decreased in males and increased in females. Aged monkeys had increased number of peroxisomes per hepatocyte with increased volume fraction. These results indicate significant differences in the magnitude and direction of peroxisome changes, reflecting species-dependent organelle response to hypolipidemic agents. The order of susceptibility of peroxisome proliferation in laboratory animals is dog less than monkey less than hamster less than rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6586630     DOI: 10.1002/hep.1840040328

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Fluorescent co-localization of PTS1 and PTS2 and its application in analysis of the gene function and the peroxisomal dynamic in Magnaporthe oryzae.

Authors:  Jiao-Yu Wang; Xiao-Yan Wu; Zhen Zhang; Xin-Fa Du; Rong-Yao Chai; Xiao-Hong Liu; Xue-Qin Mao; Hai-Ping Qiu; Yan-Li Wang; Fu-Cheng Lin; Guo-Chang Sun
Journal:  J Zhejiang Univ Sci B       Date:  2008-10       Impact factor: 3.066

2.  Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

4.  Peroxisomes in mice fed a diet supplemented with low doses of fish oil.

Authors:  C Van den Branden; D De Craemer; M Pauwels; J Vamecq
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

5.  Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators.

Authors:  J C Hanselman; M A Vartanian; B P Koester; S A Gray; A D Essenburg; T J Rea; C L Bisgaier; M E Pape
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

6.  High content screening for non-classical peroxisome proliferators.

Authors:  Jonathan Z Sexton; Qingping He; Lawrence J Forsberg; Jay E Brenman
Journal:  Int J High Throughput Screen       Date:  2010-07

Review 7.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.

Authors:  J Pill; A Völkl; F Hartig; H D Fahimi
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

9.  Peroxisome induction potential and lipid-regulating activity in rats. Quantitative microscopy and chemical structure-activity relationships.

Authors:  E J McGuire; J A Lucas; R H Gray; F A de la Iglesia
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

10.  Application of automatic image analysis for morphometric studies of peroxisomes stained cytochemically for catalase. II. Light-microscopic application.

Authors:  K Beier; H D Fahimi
Journal:  Cell Tissue Res       Date:  1987-01       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.